Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of RIVALTO vs Xarelto 20 mg under fed conditions in healthy Thai volunteers
TCTR20240808001Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rivaroxaban (2 arms), sponsored by International Bio Service. Status: unknown.
02
Drugs
rivaroxaban
Beyond the preview
Go deeper on TCTR20240808001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240808001.